April 20 (Reuters) - Oasmia Pharmaceutical Ab OASM.ST
* Oasmia's lead cancer product Paclical receives market approval in the Russian federation
* Paclical is planned for launch in the second half of 2015 Source text for Eikon: ID:nEQ9R7J6ga Further company coverage: OASM.ST